In August, the U.S. Food and Drug Administration will release the results of a study on the safety of ADHD drugs. Though several companies sell ADHD medications, Shire relies more than others heavily on the sale of its ADHD drug, Adderall
“In 2005 Adderall was briefly suspended from sale in Canada because of 20 sudden deaths and 12 strokes among mainly child users. However, the product was later allowed back into the market with a ‘black box warning’ about use by patients with underlying cardiovascular problems.” [Source: The Guardian]
The FDA study of ADHD medication began in 2007 as concern over health risks such as heart attacks and strokes began to increase.
Posted By: 4ADHD.com